Matthew Duncan Helm

Title: Inventor Spotlight: Matthew Duncan Helm

Introduction

Matthew Duncan Helm is a notable inventor based in Craigavon, Great Britain. With a strong focus on pharmaceutical innovations, Helm has made significant contributions to the field, holding a total of two patents that highlight his expertise in the realm of medical chemistry.

Latest Patents

Helm's latest patents contribute to advancements in therapeutic agents. The first patent involves pharmaceutical compounds that relate to inhibitors of the ubiquitin-specific protease USP19. This invention encompasses compounds of Formula (I), which are designed to improve therapeutic methods. His second patent focuses on piperidine derivatives as inhibitors of ubiquitin-specific protease 7 (USP7), offering promising methods of use in various applications.

Career Highlights

Matthew Duncan Helm is associated with Almac Discovery Limited, a company known for its commitment to drug discovery and development. Through his work there, Helm is at the forefront of developing new therapeutic strategies that can potentially revolutionize treatment protocols in various medical fields.

Collaborations

During his career, Helm has collaborated with talented professionals in the industry, including Peter Hewitt and Frank Burkamp. These partnerships enhance the combination of skills and knowledge necessary to drive innovation in pharmaceuticals and expand the horizons of medical research.

Conclusion

Matthew Duncan Helm exemplifies the qualities of a dedicated inventor, with a clear focus on creating impactful solutions in the pharmaceutical sector. His innovative patents and collaborative spirit within Almac Discovery Limited mark him as a significant figure in the landscape of medicinal chemistry.